Anixa Biosciences, Inc. - ANIX
About Gravity Analytica
Recent News
- 06.10.2025 - Anixa Biosciences' Breast Cancer Vaccine Receives National News Coverage
- 06.09.2025 - Anixa Biosciences Announces Poster Presentation on Ovarian Cancer CAR-T Clinical Trial at the ESMO Gynaecological Cancers Congress 2025
- 06.06.2025 - SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership
- 06.05.2025 - 4 - Statement of changes in beneficial ownership of securities
- 06.03.2025 - Anixa Biosciences' Breast Cancer Vaccine Featured in NewsNation Interview
- 06.02.2025 - Anixa Biosciences Announces Completion of Enrollment in Phase 1 Trial of Breast Cancer Vaccine
- 05.28.2025 - 10-Q - Quarterly report [Sections 13 or 15(d)]
- 05.19.2025 - Anixa Biosciences CEO Provides Letter to Shareholders Outlining Significant Progress and Advancement Towards Potentially Transformative Milestones
- 05.12.2025 - Anixa Biosciences Announces Poster Presentation on Ovarian Cancer CAR-T Clinical Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting
- 04.30.2025 - Anixa Biosciences to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference on May 20th